Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Dec 19, 2016 10:25am
177 Views
Post# 25618940

RE:RE:RE:RE:Further thoughts re the RVX update

RE:RE:RE:RE:Further thoughts re the RVX updateGV, I do believe he mentioned the possibility of going to the market as one of the options. I'm not opposed to dilution as the upside IMHO is huge and once a BP bites we'll all be happy.

Excellent posts by fouremm and torpedoman on Agora re their AGM notes. A few items I recall;
  1. Don admitted he was not dealing with the top executive levels of BP companies.
  2. He said BP will only pay attention to RVX when a very solid successfup BETonMACE is demonstrated.
  3. Regarding the licensing Don said...we missed it...with no elaboration beyond they are still in discussions.
  4. Don said the tax pool at RVX is now $250,000,000...possibly attractive to BPs that now have to repatriate their profits back to a fair tax rate in the USA.
  5. He dismissed the idea of a USA stock listing because it is too expensive and he said it would not achieve their goals (this is a very important signal to me as it says IMHO that he knows he'll get financing to carry on until they hit a major milestone, i.e. successful BoM, at which point the demand will be there from all angles...BP, licensing partners, investors, etc).
  6. BETonMACE about 800 out of 2400 enrolled.
  7. Both fouremm and torpedoman said that Don seemed confident and positive. I'm not surprised by that because he knows the science is in good hands and proceeding well, he knows he will get the financing done including the LOC and he is personally well financed.

My current opinion is that RVX has a long way to go before before any investors need to start considering it (of course unless they just want to gradually build a long position).

As I have mentioned previously I think that Zenith holds more hope for generating a return in the relatively near future. IF the zen3694 mCRPC trail on it's own or with enzalutimide succeeds I do think it will draw interest.

Interestingly, the share price did not get crushed by Don's presentations from what I saw.

The other thing that still has me puzzled is the dramatic share and volume rise that started on Sept 13 th 2016 because the updates did not give us insight on this.

Check out foureem and torpedoman's comments.
GLTA.
Toinv


Bullboard Posts